Immunotherapy of Cancer

This publication has 12 references indexed in Scilit:

• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
  The Journal of Experimental Medicine, 1996
• Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
  The Journal of Experimental Medicine, 1996
• Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor
  Journal of Immunotherapy, 1995
• Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1995
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
  Journal of Clinical Laboratory Analysis, 1991
• Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
  The Journal of Experimental Medicine, 1990
• Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
  Annals of Surgery, 1989
• Immunotherapy of cancer using interleukin 2: current status and future prospects
  Immunology Today, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987